We’re excited to announce the third session of our 𝗟𝗮𝗯𝗜𝗡𝗔𝗥 𝗕𝗥𝗘𝗔𝗞 online series! This time we’ll explore the pivotal role of hiPSC-derived atrial and ventricular cardiomyocytes in preclinical drug discovery. On September 19th at 4 PM CEST (10AM ET, 7AM PDT), we’ll be joined by Jamie Bhagwan from Axol Bioscience Ltd., who will present findings on differential contractility responses of axoCells™ hiPSC-derived atrial and ventricular cardiomyocytes when exposed to GPCR and ion channel modulating compounds. Whether you're a scientist, researcher, or simply passionate about the latest advances in cardiac research, this session is not to be missed! Register here and be part of the conversation! https://lnkd.in/eg4x5B-w #webinar #LabinarBreak #cardiacsafety #preclinical #drugevelopment #atrialfibrillation #iPS #cardiomyocytes #
Dieser Inhalt ist hier nicht verfügbar.
Mit der LinkedIn App können Sie auf diese und weitere Inhalte zugreifen.